E-therapeutics Plc
OTC: ETXPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Ahmad Ali Mortazavi
- Employees
- 39
- Headquarters
- London, United Kingdom
- IPO year
- 2020
- Market cap
- $76.0M
- Website
- https://www.etherapeutics.co.uk
Loading ETXPF…
Loading profile data…Frequently asked questions about ETXPF
What does E-therapeutics Plc (ETXPF) do?
E-therapeutics Plc is a UK-based company focused on drug discovery. The core of its work involves a sophisticated computational platform that employs in-silico screening and unique network models to identify and predict which compounds or biological targets can effectively alter relevant biological processes. Furthermore, the company is advancin...
Where does ETXPF trade?
E-therapeutics Plc (ETXPF) trades on the Other OTC.
What sector is ETXPF in?
E-therapeutics Plc (ETXPF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of E-therapeutics Plc?
Ahmad Ali Mortazavi is the chief executive officer of E-therapeutics Plc (ETXPF).
Where is E-therapeutics Plc headquartered?
E-therapeutics Plc is headquartered in United Kingdom.
Does ETXPF pay a dividend?
E-therapeutics Plc (ETXPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ETXPF go public?
E-therapeutics Plc (ETXPF) completed its initial public offering in 2020.